ECARX Holdings Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $847.9M+9.9% YoYTTM through 31 Dec 2025
Net Income -$66MTTM through 30 Jun 2025
Free Cash Flow -$106.6MTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 19.0% |
| EBITDA Margin | -4.1% |
| Operating Margin | -6.5% |
| Net Margin | -7.8% |
Returns
23.4%ROE
-10.0%ROA
Balance Sheet Health
Debt / Equity-1.10x
Current Ratio0.59x
Net Debt$223.5M
Cash & Equivalents$87.1M
Quality Metrics
Altman Z-Score-1.85
Piotroski F-Score2 / 9
FCF Margin-12.6%
Rule of 4021.4
Earnings-Beat Rate25.0%
Multi-Year Trend
RevenueFY2025: $847.9M
Diluted EPS-$0.20TTMFY2025: $-0.20
Dividend
No dividend
Capital Allocation
R&D Spend$123.3M
Capex Intensity1.4%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.